始めましょう
ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

トレードなし
スーパーチャートで確認
概要 ファンダメンタル ニュース 議論 テクニカル 予測 季節性
債券

債券: ABBV

以下はABBVIE INCの社債のリストです。市場のボラティリティが高まった時に社債の安定感は増す、という理由で選ばれることが多いものです。価格や利回りなどの統計データを研究して、信頼の置ける投資先を見つけましょう。
シンボル
最終利回り %
出来高
価格 %
クーポン %
満期日
発行残高
額面金額
最低額面
発行体
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
7.59%150 K77.52%4.63%2042-10-0167.49 M USD1,000.00 USD2,000.00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7.40%15 K79.63%4.85%2044-06-1565.23 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7.28%10 K79.20%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AA5QDALLERGAN FNDG 15/25
7.15%099.26%3.80%2025-03-15130.22 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
6.91%60 K85.86%4.55%2035-03-15107.65 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
6.08%7.88 M81.87%4.25%2049-11-215.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
6.06%084.97%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5.95%088.48%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5.90%2.3 M88.93%4.63%2042-10-01389.22 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5.86%1.48 M89.70%4.75%2045-03-15827.09 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5.86%935 K87.25%4.40%2042-11-062.6 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5.85%8.41 M85.67%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5.84%1.7 M90.40%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5.81%2.11 M91.21%4.85%2044-06-151.01 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.81%4.27 M96.28%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5.68%15.52 M96.89%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5.62%1.68 M97.52%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5.56%091.23%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5.48%093.50%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5.39%2.02 M94.48%4.55%2035-03-151.68 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5.19%10.13 M99.10%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.10%20 K92.50%3.20%2029-11-2162.52 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
5.05%9.88 M92.71%3.20%2029-11-215.44 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.98%4.02 M99.88%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4.96%099.48%3.60%2025-05-143.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4.86%8.25 M99.76%3.80%2025-03-152.89 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4.85%3.42 M99.82%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4.75%2.68 M98.37%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4.66%098.09%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4.63%2.53 M97.04%2.95%2026-11-213.99 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4.59%1.34 M100.43%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
4.11%095.03%2.63%2028-11-1572.11 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3.86%096.53%2.95%2026-11-219.24 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XXS162262122ALLERGAN FNDG 17/29
3.80%093.63%2.13%2029-06-0136.46 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
4ABGABBVIE 19/31
3.02%089.86%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
3.01%0102.15%3.80%2025-03-151.27 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2.90%0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2.88%0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS152090781ABBVIE 16/28
2.84%097.49%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2.83%0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS212591483ABBVIE 20/28
2.76%099.52%2.63%2028-11-15427.79 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2.76%097.49%2.13%2029-06-01506.09 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2.64%094.91%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.35%0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3.80%2025-03-15—1,000.00 USD2,000.00 USDAbbVie, Inc.